125 related articles for article (PubMed ID: 12943944)
21. Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study.
Navarro V; Gastó C; Torres X; Marcos T; Pintor L
Acta Psychiatr Scand; 2001 Jun; 103(6):435-40. PubMed ID: 11401657
[TBL] [Abstract][Full Text] [Related]
22. Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants.
Souêtre E; Martin P; Lozet H; Monteban H
Int Clin Psychopharmacol; 1996 Mar; 11(1):45-52. PubMed ID: 8732313
[TBL] [Abstract][Full Text] [Related]
23. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
Samuelian JC; Hackett D
J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
26. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
27. Fluoxetine and cyclosporine in organ transplantation. Failure to detect significant drug interactions or adverse clinical events in depressed organ recipients.
Strouse TB; Fairbanks LA; Skotzko CE; Fawzy FI
Psychosomatics; 1996; 37(1):23-30. PubMed ID: 8600490
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression.
Agosti V; McGrath PJ
J Affect Disord; 2002 Sep; 71(1-3):113-20. PubMed ID: 12167507
[TBL] [Abstract][Full Text] [Related]
29. Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Sullivan PF; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):376-83. PubMed ID: 12060187
[TBL] [Abstract][Full Text] [Related]
30. Predictors of an acute antidepressant response to fluoxetine and sertraline.
Flament MF; Lane RM; Zhu R; Ying Z
Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
[TBL] [Abstract][Full Text] [Related]
31. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
32. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine.
Vázquez-Palacios G; Bonilla-Jaime H; Velázquez-Moctezuma J
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):39-46. PubMed ID: 15610943
[TBL] [Abstract][Full Text] [Related]
33. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
[TBL] [Abstract][Full Text] [Related]
34. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.
Onder E; Tural U
J Affect Disord; 2003 Sep; 76(1-3):223-7. PubMed ID: 12943952
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular effects of fluoxetine in depressed patients with heart disease.
Roose SP; Glassman AH; Attia E; Woodring S; Giardina EG; Bigger JT
Am J Psychiatry; 1998 May; 155(5):660-5. PubMed ID: 9585718
[TBL] [Abstract][Full Text] [Related]
36. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
[TBL] [Abstract][Full Text] [Related]
37. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
Gendall KA; Joyce PR; Mulder RT; Luty SE
J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
[TBL] [Abstract][Full Text] [Related]
38. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
39. Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group.
Small GW; Birkett M; Meyers BS; Koran LM; Bystritsky A; Nemeroff CB
J Am Geriatr Soc; 1996 Oct; 44(10):1220-5. PubMed ID: 8856002
[TBL] [Abstract][Full Text] [Related]
40. Ecto-nucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline.
Pedrazza EL; Rico EP; Senger MR; Pedrazza L; Zimmermann FF; Sarkis JJ; Bogo MR; Bonan CD
Eur J Pharmacol; 2008 Mar; 583(1):18-25. PubMed ID: 18280468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
